Richard C. Harmon cytact at netcom.com
Mon Aug 28 22:11:58 EST 1995

The FDA OK'ed use of thalidomide for compassionate use in AIDS-related
cachexia.  The company that got permission for the expanded testing is
named Celgene, which specializes in the synthesis of chiral intermediates. 
Does anyone know how the manufacturing process may have taken the bite out
of the thalidomide stigma?  I'd appreciate any feedback.  Thanks. 

--   Recycle, reuse, buy tomatoes (correct, Dan?) with flaws.
--                                         cytact at netcom.com

More information about the Toxicol mailing list

Send comments to us at biosci-help [At] net.bio.net